Choroidal Change on OCTA in Eyes With High Myopia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-55
SponsorThe First Affiliated Hospital with Nanjing Medical University
About this trial
Myopia is a global healthy concern, especially the high myopia and pathological myopia among Asian populations. However, its mechanism still remains largely unclear. Recent findings suggested choroidal changes might be related to the development of myopia. This study is to useOCT angiography (OCT-A) to investigate parapapillary choroidal microvasculature change in myopic eyes, and try to find the cause-and-effect relationship between choroidal change and the development of myopia.
Eligibility criteria
Qualifiers
Spherical equivalent measurement can be included in above 4 groups
Willing to be followed up in the future 10 years
Disqualifiers
Deny to sign the patient consent, or deny to be followed
Evidence of cardiac, or diabetic, or CNS disease.
Clinically diagnosed with retinal or choroidal disease
Glucoma
Trial design
Treatments tested in this trial
- Optic coherence tomography angiography (OCTA)
Treatment groups
200 Participants
are divided into 4 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov